Table of Contents
Volume 7 | Supplement 4
Publication Date: May 2006- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S109-S110 |
The Way Forward: New Drugs and New Therapeutic Strategies in Lung Cancer Therapy Giorgio V. Scagliotti, Silvia Novello |
|
Contributions | ||
S111-S117 |
Current Approaches to Advanced-Stage Non–Small-Cell Lung Cancer: First-Line Therapy in Patients with a Good Functional Status Thomas E. Stinchcombe, Carrie B. Lee, Mark A. Socinski |
|
S118-S125 |
Second-Line Treatment for Advanced-Stage Non–Small-Cell Lung Cancer: Current and Future Options Cheryl Ho, Angela M. Davies, Primo N. Lara, Jr, David R. Gandara |
|
S126-S137 |
Neglected and Underrepresented Subpopulations: Elderly and Performance Status 2 Patients with Advanced-Stage Non–Small-Cell Lung Cancer Corey J. Langer |
|
S138-S144 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer: Impact of Primary or Secondary Mutations Akira Sakurada, Frances A. Shepherd, Ming-Sound Tsao |
|
S145-S149 |
Angiogenesis Inhibitors in Lung Cancer: A Promise Fulfilled Grace K. Dy, Alex A. Adjei |
|